Optiver Holding
IMVT icon

Optiver Holding’s Immunovant IMVT Stock Holding History

Optiver Holding’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2K Buy
368
+309
+524% +$9.41K ﹤0.01% 1649
2026
Q1 		$1.47K Sell
59
-38
-39% -$984 ﹤0.01% 1970
2025
Q4 		$2.47K Sell
97
-324
-77% -$7.22K ﹤0.01% 1894
2025
Q3 		$6.79K Buy
421
+274
+186% +$4.44K ﹤0.01% 1530
2025
Q2 		$2.35K Buy
+147
New +$2.22K ﹤0.01% 1336

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Optiver Holding's IMVT Position: Q2 2026 in Review

Optiver Holding increased its Immunovant (IMVT) stake by 524% in Q2 2026, buying an estimated $9.41K and bringing the position to 368 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Optiver Holding first reported a position in IMVT in Q2 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Optiver Holding held 368 shares of Immunovant worth $14.2K as of Q2 2026.
  • Optiver Holding bought 309 Immunovant shares in Q2 2026, an estimated $9.41K.
  • Immunovant made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1649 holding.
  • Optiver Holding first reported a position in Immunovant in Q2 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.